Bipartisan lawmakers press FDA to close peptide loophole
The letter targets the regulatory gap that lets unapproved peptide products reach consumers outside the approved-drug pathway.
DO
By Daniel Okafor · Regulatory Correspondent
Oct 20 17:50 ETSource: STAT
The wire
- 01A bipartisan group of lawmakers has urged the Food and Drug Administration to close what they describe as a loophole in how peptide products are regulated.
- 02Any FDA response would bear directly on compounders, telehealth prescribers and research-peptide sellers operating in the current gray zone.
- 03No agency action has been announced, and the scope of any rulemaking or enforcement that follows is not yet defined.
From the source
Read at statnews.comA bipartisan group of lawmakers urges the FDA to close a peptide loophole
